News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bioLyticalâ„¢ Laboratories Receives FDA Clearance to Initiate Clinical Trial for 60-Second HIV Test


7/10/2007 1:05:18 PM

VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jul 10, 2007 -- bioLytical Laboratories (bioLytical) announced today the U.S. Food and Drug Administration (FDA) has accepted the Investigational Device Exemption (IDE) application for INSTI(TM), a 60-second rapid HIV test for point-of-care testing. The acceptance clears the way for bioLytical to immediately begin its US clinical trials.

Read at Market Wired

comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES